Effect of Extended Infusion Lines on Pulse Contour-based Measurements

October 9, 2019 updated by: Dr. Alain Kalmar, MD, PhD, Algemeen Ziekenhuis Maria Middelares

Evaluation of the Effect of Different Types of Extended Infusion Lines on Pulse Contour-based Measurements Based on the Arterial Pressure Signal

Hemodynamic monitoring of the critically-ill patients is increasingly performed using an arterial pulse contour-based cardiac output device such as the proAQT system.

The aim of this study is to evaluate the effect of extending the pressure lines on the arterial pressure wave and the calculated hemodynamic variables when using the proAQT system.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Hemodynamic continuous monitoring of critically-ill patients is increasingly performed with minimally-invasive methods, such as the proAQT sensor (PULSION Medical Systems SE, Munich, Germany).

The proAQT sensor calculates hemodynamic variables such as the cardiac output, stroke volume (variation), pulse-pressure variation and systemic vascular resistance by pulse contour analysis of the arterial pressure waveform using an arterial radial or femoral catheter. This minimal invasive technique, also permits continuous beat-to-beat assessment.

In patients in who an arterial catheter is placed for clinical reasons, the hemodynamic variables are continuously recorded. An extension line is coupled to a 3-way stopcock, connected to the proAQT sensor. In a neutral position of the 3-way stopcock, the pressure wave travels from the pressure sensor through the standard line. By turning the handle of the stopcock the standard line is bypassed and the pressure wave travels through the extended line.

The hemodynamic registration will be as follows:

  • two minutes in the neutral position;
  • two minutes with one type of extension line
  • two minutes in the neutral position
  • two minutes with a second type of extension line
  • two minutes in neutral position

The arterial pressure curve and all calculated hemodynamic variables are electronically registered.

The influence of two types of extension lines on the accuracy of the calculated hemodynamic variables will be evaluated by comparing the variables measured in neutral position and variables measured with the extended pressure lines. The changes in the calculated variables will be correlated to possible arterial pressure waveform modifications and used to evaluate different algorithms, which might be used to reconstruct the primary pressure wave.

Study Type

Observational

Enrollment (Actual)

10

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oost-Vlaanderen
      • Ghent, Oost-Vlaanderen, Belgium, 9000
        • AZ Maria Middelares

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Adult hospitalized patients for which arterial pressure measurement is needed.

Description

Inclusion Criteria:

  • ASA 1-2
  • arterial catheter necessary for clinical reasons

Exclusion Criteria:

  • ≥ASA 3

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Pulse contour disturbance
Patients with an arterial catheter and pressure line extensions.

Two types of extension lines are connected:

  • Perfusor® line 150cm (polyethylene)
  • conventional arterial extension line

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
relative change in ProAQT-calculated cardiac output after placement of extension lines.
Time Frame: one minute of measurement after changing the length of the extension line.
relative change (in % of the baseline measurement) in cardiac output following increase in length of the extension line.
one minute of measurement after changing the length of the extension line.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change in Area Under the Curve (AUC) of the arterial pressure wave form after placement of extension lines.
Time Frame: one minute of measurement after changing the length of the extension line.
The relative chane in AUC of the arterial pressure curve (from start systole to dicrotic notch) following increase in length of the extension line.
one minute of measurement after changing the length of the extension line.
relative change in ProAQT-calculated SVR after placement of extension lines.
Time Frame: one minute of measurement after changing the length of the extension line.
relative change (in % of the baseline measurement) in systemic vascular resistance following increase in length of the extension line.
one minute of measurement after changing the length of the extension line.
relative change in ProAQT-calculated diastolic blood pressure after placement of extension lines.
Time Frame: one minute of measurement after changing the length of the extension line.
relative change (in % of the baseline measurement) in diastolic blood pressure following increase in length of the extension line.
one minute of measurement after changing the length of the extension line.
relative change in ProAQT-calculated systolic blood pressure after placement of extension lines.
Time Frame: one minute of measurement after changing the length of the extension line.
relative change (in % of the baseline measurement) in systolic blood pressure following increase in length of the extension line.
one minute of measurement after changing the length of the extension line.
relative change in ProAQT-calculated stroke volume variation after placement of extension lines.
Time Frame: one minute of measurement after changing the length of the extension line.
relative change (in % of the baseline measurement) in stroke volume variation following increase in length of the extension line.
one minute of measurement after changing the length of the extension line.
relative change in ProAQT-calculated pulse pressure variation after placement of extension lines.
Time Frame: one minute of measurement after changing the length of the extension line.
relative change (in % of the baseline measurement) in pulse pressure variation following increase in length of the extension line.
one minute of measurement after changing the length of the extension line.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alain Kalmar, MD, PhD, MSc, Maria Middelares Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 15, 2018

Primary Completion (Actual)

December 15, 2018

Study Completion (Actual)

December 30, 2018

Study Registration Dates

First Submitted

June 20, 2018

First Submitted That Met QC Criteria

July 16, 2018

First Posted (Actual)

July 26, 2018

Study Record Updates

Last Update Posted (Actual)

October 10, 2019

Last Update Submitted That Met QC Criteria

October 9, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • MMS.2018.004

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemodynamic Instability

Clinical Trials on Pressure line extensions

3
Subscribe